ArticleJACC. Case reports2025

Left Ventricular Dysfunction Caused by Combined Pembrolizumab and Lenvatinib Following Doxorubicin: Which Agent Is the Culprit?

Yoshihide Ishikawa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.